Bleeding risk assessment during oral anticoagulant therapy initiation

被引：0
作者：
Lazo-Langner, Alejandro [1 ,2 ]
Kovacs, Michael J. [1 ]
Louzada, Martha [1 ]
机构：
[1] Univ Western Ontario, Dept Med, London, ON, Canada
[2] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
来源：
EXPERT REVIEW OF HEMATOLOGY | 2012年 / 5卷 / 02期
关键词：
anticoagulant; atrial fibrillation; bleeding; clinical prediction rules; risk assessment; venous thromboembolism; CLINICAL CLASSIFICATION SCHEMES; ATRIAL-FIBRILLATION; VENOUS THROMBOEMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; VALIDATION; RECURRENCE; HEMORRHAGE; EVENTS;
D O I：
10.1586/EHM.12.10
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 127
页数：3
相关论文
共 50 条
  • [31] The effects of anticoagulant therapy re-initiation after gastrointestinal bleeding: A systematic review and meta-analysis
    Xu Bingzheng
    Ren Jingnan
    Bao Ligang
    Chen Jianping
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1509 - 1518
  • [32] Patients treated with vitamin K oral anticoagulants in family practice: a new approach to bleeding risk assessment. An ancillary study by the CACAO prospective general practice cohort
    Gaboreau, Yoann
    Frappe, Paul
    Vermorel, Celine
    Foote, Alison
    Bosson, Jean-Luc
    Pernod, Gilles
    FAMILY PRACTICE, 2024,
  • [33] Oral anticoagulant therapy in older adults
    Stuby, J.
    Haschke, M.
    Tritschler, T.
    Aujesky, D.
    THROMBOSIS RESEARCH, 2024, 238 : 1 - 10
  • [34] Risk of gastrointestinal bleeding during anticoagulant treatment
    Lanas-Gimeno, Aitor
    Lanas, Angel
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 673 - 685
  • [35] Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes
    Tinkham, Tyler T.
    Vazquez, Sara R.
    Jones, Aubrey E.
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (03) : 492 - 496
  • [36] Gastrointestinal Bleeding During Direct Oral Anticoagulant Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of Polypharmacy
    Honda, Taku
    Abe, Koichiro
    Oda, Minoru
    Harada, Fumito
    Maruyama, Kyohei
    Aoyagi, Hitoshi
    Miura, Ryo
    Konno, Kumiko
    Arizumi, Toshihiko
    Asaoka, Yoshinari
    Kodashima, Shinya
    Kozuma, Ken
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12) : 1548 - 1556
  • [37] Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension
    Gabriel, Laurence
    Delavenne, Xavier
    Bedouch, Pierrick
    Khouatra, Chahera
    Bouvaist, Helene
    Cordier, Jean-Francois
    Mornex, Jean-Francois
    Pison, Christophe
    Cottin, Vincent
    Bertoletti, Laurent
    RESPIRATION, 2016, 91 (04) : 307 - 315
  • [38] Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment
    Lind, Marcus
    Jansson, Jan-Hakan
    Nilsson, Torbjorn K.
    Jarvholm, Lisbeth Slunga
    Johansson, Lars
    THROMBOSIS RESEARCH, 2013, 132 (02) : E77 - E82
  • [39] Prediction of bleeding events using the VTE-BLEED risk score in patients with venous thromboembolism receiving anticoagulant therapy (Review)
    Badescu, Minerva Codruta
    Ciocoiu, Manuela
    Badulescu, Oana Viola
    Vladeanu, Maria-Cristina
    Bojan, Iris Bararu
    Vlad, Cristiana Elena
    Rezus, Ciprian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [40] Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
    Cid, Allison
    Smetana, Megan E.
    Hebert, Courtney
    Coe, Kelci
    Smith, Jessica M.
    PHARMACOTHERAPY, 2022, 42 (12): : 880 - 889
12345